Coverart for item
The Resource Countering the problem of falsified and substandard drugs, Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies, (electronic resource)

Countering the problem of falsified and substandard drugs, Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies, (electronic resource)

Label
Countering the problem of falsified and substandard drugs
Title
Countering the problem of falsified and substandard drugs
Statement of responsibility
Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies
Creator
Contributor
Subject
Language
eng
Summary
  • "The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines"--Publisher's description
  • "The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines"--Publisher's description
Cataloging source
NRC
Dewey number
338.4/76151
Funding information
Supported by the National Academy of Sciences and the U.S. Food and Drug Administration
NLM call number
  • 2013 J-834
  • QV 773
http://bibfra.me/vocab/lite/organizationName
Institute of Medicine (U.S.)
http://library.link/vocab/relatedWorkOrContributorName
  • Buckley, Gillian J
  • Gostin, Lawrence O.
http://library.link/vocab/subjectName
  • Counterfeit Drugs
  • Fraud
  • Drug Contamination
  • Pharmaceutical Preparations
  • Quality Control
  • International Cooperation
Label
Countering the problem of falsified and substandard drugs, Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies, (electronic resource)
Instantiates
Publication
Bibliography note
Includes bibliographical references
Contents
  • The effects of falsified and substandard drugs -- The magnitude of the problem -- Causes of falsified and substandard drugs -- Weaknesses in the drug distribution chain -- Detection technology -- An international code of practice for falsified and substandard medicines
  • The effects of falsified and substandard drugs -- The magnitude of the problem -- Causes of falsified and substandard drugs -- Weaknesses in the drug distribution chain -- Detection technology -- An international code of practice for falsified and substandard medicines
Control code
OCM1bookssj0001119888
Dimensions
unknown
Isbn
9780309269391
Specific material designation
remote
System control number
(WaSeSS)bookssj0001119888
Label
Countering the problem of falsified and substandard drugs, Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies, (electronic resource)
Publication
Bibliography note
Includes bibliographical references
Contents
  • The effects of falsified and substandard drugs -- The magnitude of the problem -- Causes of falsified and substandard drugs -- Weaknesses in the drug distribution chain -- Detection technology -- An international code of practice for falsified and substandard medicines
  • The effects of falsified and substandard drugs -- The magnitude of the problem -- Causes of falsified and substandard drugs -- Weaknesses in the drug distribution chain -- Detection technology -- An international code of practice for falsified and substandard medicines
Control code
OCM1bookssj0001119888
Dimensions
unknown
Isbn
9780309269391
Specific material designation
remote
System control number
(WaSeSS)bookssj0001119888

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...